PE20150674A1 - Azaheterociclos como inhibidores de bir2 y/o bir3 - Google Patents

Azaheterociclos como inhibidores de bir2 y/o bir3

Info

Publication number
PE20150674A1
PE20150674A1 PE2015000194A PE2015000194A PE20150674A1 PE 20150674 A1 PE20150674 A1 PE 20150674A1 PE 2015000194 A PE2015000194 A PE 2015000194A PE 2015000194 A PE2015000194 A PE 2015000194A PE 20150674 A1 PE20150674 A1 PE 20150674A1
Authority
PE
Peru
Prior art keywords
azaheterocicles
bir2
bir3
inhibitors
compounds
Prior art date
Application number
PE2015000194A
Other languages
English (en)
Inventor
Joan Heather Hogg
Kang Le
Yan Lou
Steven Gregory Mischke
Stacy W Remiszewski
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48948413&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20150674(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PE20150674A1 publication Critical patent/PE20150674A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/4035—Isoindoles, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

La invencion se describe por compuestos de formula l: o sales farmaceuticamente aceptables de los mismos, en la que R1, R2, R3, m, n y q se definen en la presente solicitud, y metodos de utilizacion de dichos compuestos en el tratamiento del cancer
PE2015000194A 2012-08-15 2013-08-06 Azaheterociclos como inhibidores de bir2 y/o bir3 PE20150674A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261683253P 2012-08-15 2012-08-15

Publications (1)

Publication Number Publication Date
PE20150674A1 true PE20150674A1 (es) 2015-05-06

Family

ID=48948413

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2015000194A PE20150674A1 (es) 2012-08-15 2013-08-06 Azaheterociclos como inhibidores de bir2 y/o bir3

Country Status (21)

Country Link
US (1) US9422332B2 (es)
EP (1) EP2885275A1 (es)
JP (1) JP6203261B2 (es)
KR (1) KR20150042792A (es)
CN (1) CN104540806B (es)
AU (1) AU2013304214A1 (es)
BR (1) BR112015003201A2 (es)
CA (1) CA2878106A1 (es)
CL (1) CL2015000333A1 (es)
CO (1) CO7180196A2 (es)
CR (1) CR20150041A (es)
EA (1) EA201590347A1 (es)
HK (1) HK1209427A1 (es)
IL (1) IL237063A0 (es)
MA (1) MA37896A1 (es)
MX (1) MX2015001905A (es)
PE (1) PE20150674A1 (es)
PH (1) PH12015500185A1 (es)
SG (1) SG11201500581WA (es)
WO (1) WO2014026882A1 (es)
ZA (1) ZA201500342B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016079527A1 (en) 2014-11-19 2016-05-26 Tetralogic Birinapant Uk Ltd Combination therapy
WO2016097773A1 (en) 2014-12-19 2016-06-23 Children's Cancer Institute Therapeutic iap antagonists for treating proliferative disorders
EP3433243B8 (en) * 2016-03-22 2021-10-13 Institut National de la Santé et de la Recherche Médicale (INSERM) Novel derivatives and their use as selective inhibitors of caspase-2
CN109071525B (zh) * 2016-05-09 2022-08-19 豪夫迈·罗氏有限公司 二聚化合物
CN106265764B (zh) 2016-08-18 2018-03-16 广州威溶特医药科技有限公司 Iap抑制剂和溶瘤病毒在制备抗肿瘤药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP2007003894A0 (en) * 2004-07-12 2007-02-28 Bin Chao Tetrapeptide analogs
AU2005271831A1 (en) 2004-07-12 2006-02-16 Idun Pharmaceuticals, Inc. Tetrapeptide analogs
US8551955B2 (en) * 2009-10-28 2013-10-08 Joyant Pharmaceuticals, Inc. Dimeric Smac mimetics

Also Published As

Publication number Publication date
HK1209427A1 (en) 2016-04-01
CA2878106A1 (en) 2014-02-20
KR20150042792A (ko) 2015-04-21
ZA201500342B (en) 2017-09-27
IL237063A0 (en) 2015-03-31
CN104540806B (zh) 2017-05-03
PH12015500185B1 (en) 2015-04-20
US9422332B2 (en) 2016-08-23
JP2015526436A (ja) 2015-09-10
US20150210739A1 (en) 2015-07-30
EP2885275A1 (en) 2015-06-24
SG11201500581WA (en) 2015-04-29
WO2014026882A1 (en) 2014-02-20
AU2013304214A1 (en) 2015-02-12
MX2015001905A (es) 2015-06-05
CN104540806A (zh) 2015-04-22
PH12015500185A1 (en) 2015-04-20
CL2015000333A1 (es) 2015-11-06
EA201590347A1 (ru) 2015-05-29
JP6203261B2 (ja) 2017-09-27
CR20150041A (es) 2015-03-13
CO7180196A2 (es) 2015-02-09
BR112015003201A2 (pt) 2017-07-04
MA37896A1 (fr) 2016-09-30

Similar Documents

Publication Publication Date Title
CY1122266T1 (el) Ενωσεις 3-αμινοκυκλοαλκυλιου ως ror-gamma-t αναστολεις και χρησεις αυτων
ECSP22091792A (es) Compuestos tricíclicos sustituidos como inhibidores del receptor del factor de crecimiento de fibroplastos
CL2017002483A1 (es) Compuestos heterocíclicos como inhibidores de lsd1
ECSP16076566A (es) Compuestos de heteroarilo o arilo biciclicos fusionados y su aplicación a inhibidores de irak4
CR20140464A (es) Compuestos de heterociclilo
CO6630162A2 (es) Derivados del ácido 1-amino -2-ciclopropiletilboronico
BR112017006305A2 (pt) compostos heteroarila como inibidores de btk e usos dos mesmos
CO7160104A2 (es) Inhibidores de virus de hepatitis c
CR20140166A (es) Compuestos de (hetero)arilciclopropilamina como inhibidores de lsd1
UY35898A (es) ?compuestos inhibidores de syk y composiciones que los comprenden?.
CR20150211A (es) Compuestos diméricos
CR20210079A (es) Sulfamoilarilamidas y su uso como medicamentos para el tratamiento de la hepatitis b
UY35395A (es) Inhibidores de bromodominios tetracíclicos
ECSP12012103A (es) Inhibidores de virus flaviviridae.
CO6670585A2 (es) Promotores de apotosis n-acilsufonamidas
CR20150571A (es) Compuestos y composiciones terapéuticos
CR20150250A (es) Nuevos derivados de piridina
PE20151023A1 (es) Triazolopirazinas
CR20140399A (es) Pirrolidina-2-carboxamidas sustituidas
CR20150061A (es) Compuesto de pirazolopirimidinas
UY33885A (es) Inhibición de la il17 y del ifn-gamma para el tratamiento de las inflamaciones autoinmunes
UY35419A (es) Inhibidores de cdk9 quinasa de pirrolo (2,3- b) piridina
PE20151669A1 (es) Compuestos de azetidiniloxifenilpirrolidina
BR112014030720A8 (pt) composto, composição farmacêutica e usos de inibidores de fbx03
PE20150674A1 (es) Azaheterociclos como inhibidores de bir2 y/o bir3

Legal Events

Date Code Title Description
FD Application declared void or lapsed